Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26762 | 246 | 36.2 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
272 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 43768 |
534 | 2 | ANDROGEN RECEPTOR//PROSTATE CANCER//CASTRATION RESISTANT PROSTATE CANCER | 14838 |
26762 | 1 | SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS | 246 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SELECTIVE ANDROGEN RECEPTOR MODULATOR | authKW | 2250661 | 13% | 58% | 31 |
2 | SARM | authKW | 1401884 | 10% | 47% | 24 |
3 | SARMS | authKW | 1216440 | 6% | 70% | 14 |
4 | PREVENT DOPING | address | 567312 | 14% | 13% | 35 |
5 | JS 38 | authKW | 248255 | 1% | 100% | 2 |
6 | SELECTIVE ANDROGEN RECEPTOR MODULATORS SARMS | authKW | 248255 | 1% | 100% | 2 |
7 | DOPING PREVENT | address | 221650 | 2% | 36% | 5 |
8 | ENOBOSARM | authKW | 186188 | 1% | 50% | 3 |
9 | AR AGONIST | authKW | 165502 | 1% | 67% | 2 |
10 | GW1516 | authKW | 165502 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 3582 | 36% | 0% | 88 |
2 | Pharmacology & Pharmacy | 514 | 28% | 0% | 69 |
3 | Chemistry, Organic | 391 | 19% | 0% | 47 |
4 | Biochemical Research Methods | 335 | 13% | 0% | 32 |
5 | Chemistry, Analytical | 213 | 14% | 0% | 34 |
6 | Spectroscopy | 187 | 8% | 0% | 20 |
7 | Endocrinology & Metabolism | 163 | 11% | 0% | 27 |
8 | Crystallography | 16 | 3% | 0% | 7 |
9 | Biochemistry & Molecular Biology | 10 | 10% | 0% | 25 |
10 | Andrology | 8 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PREVENT DOPING | 567312 | 14% | 13% | 35 |
2 | DOPING PREVENT | 221650 | 2% | 36% | 5 |
3 | NEW LEADS DISCOVERY | 139634 | 2% | 19% | 6 |
4 | ANALYT CHEM ENVIRONM CHEM | 124127 | 0% | 100% | 1 |
5 | CORP MKT OFF | 124127 | 0% | 100% | 1 |
6 | DSAR DD ISOTOPE CHEM METABOLITE SYNTH | 124127 | 0% | 100% | 1 |
7 | M DISCOVERY | 124127 | 0% | 100% | 1 |
8 | METAB VIRAL DRUG DISCOVERY | 124127 | 0% | 100% | 1 |
9 | NORRIE POINT STN | 124127 | 0% | 100% | 1 |
10 | PROSKELIA | 124127 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG TESTING AND ANALYSIS | 13313 | 4% | 1% | 10 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 4528 | 11% | 0% | 28 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4136 | 12% | 0% | 29 |
4 | EUROPEAN JOURNAL OF MASS SPECTROMETRY | 3202 | 2% | 1% | 5 |
5 | EXPERT OPINION ON THERAPEUTIC PATENTS | 2000 | 2% | 0% | 6 |
6 | RAPID COMMUNICATIONS IN MASS SPECTROMETRY | 1378 | 4% | 0% | 10 |
7 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1366 | 4% | 0% | 10 |
8 | EXPERT OPINION ON DRUG DISCOVERY | 1117 | 1% | 0% | 3 |
9 | MOLECULAR INTERVENTIONS | 1041 | 0% | 1% | 1 |
10 | DEUTSCHE ZEITSCHRIFT FUR SPORTMEDIZIN | 968 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SELECTIVE ANDROGEN RECEPTOR MODULATOR | 2250661 | 13% | 58% | 31 | Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATOR | Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATOR |
2 | SARM | 1401884 | 10% | 47% | 24 | Search SARM | Search SARM |
3 | SARMS | 1216440 | 6% | 70% | 14 | Search SARMS | Search SARMS |
4 | JS 38 | 248255 | 1% | 100% | 2 | Search JS+38 | Search JS+38 |
5 | SELECTIVE ANDROGEN RECEPTOR MODULATORS SARMS | 248255 | 1% | 100% | 2 | Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATORS+SARMS | Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATORS+SARMS |
6 | ENOBOSARM | 186188 | 1% | 50% | 3 | Search ENOBOSARM | Search ENOBOSARM |
7 | AR AGONIST | 165502 | 1% | 67% | 2 | Search AR+AGONIST | Search AR+AGONIST |
8 | GW1516 | 165502 | 1% | 67% | 2 | Search GW1516 | Search GW1516 |
9 | NONSTEROIDAL LIGANDS | 165502 | 1% | 67% | 2 | Search NONSTEROIDAL+LIGANDS | Search NONSTEROIDAL+LIGANDS |
10 | 1 4 N O MIGRATION | 124127 | 0% | 100% | 1 | Search 1+4+N+O+MIGRATION | Search 1+4+N+O+MIGRATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHANG, XQ , LANTER, JC , SUI, ZH , (2009) RECENT ADVANCES IN THE DEVELOPMENT OF SELECTIVE ANDROGEN RECEPTOR MODULATORS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 19. ISSUE 9. P. 1239-1258 | 41 | 82% | 12 |
2 | MOHLER, ML , BOHL, CE , JONES, A , COSS, CC , NARAYANAN, R , HE, YL , HWANG, DJ , DALTON, JT , MILLER, DD , (2009) NONSTEROIDAL SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS): DISSOCIATING THE ANABOLIC AND ANDROGENIC ACTIVITIES OF THE ANDROGEN RECEPTOR FOR THERAPEUTIC BENEFIT.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 52. ISSUE 12. P. 3597-3617 | 57 | 46% | 84 |
3 | THEVIS, M , GEYER, H , KAMBER, M , SCHANZER, W , (2009) DETECTION OF THE ARYLPROPIONAMIDE-DERIVED SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) S-4 (ANDARINE) IN A BLACK-MARKET PRODUCT.DRUG TESTING AND ANALYSIS. VOL. 1. ISSUE 7-8. P. 387-392 | 22 | 96% | 9 |
4 | ZHANG, XQ , ALLAN, GF , TANNENBAUM, P , SBRISCIA, T , LINTON, O , LAI, MT , HAYNES-JOHNSON, D , BHATTACHARJEE, S , LUNDEEN, SG , SUI, ZH , (2013) PHARMACOLOGICAL CHARACTERIZATION OF AN IMIDAZOLOPYRAZOLE AS NOVEL SELECTIVE ANDROGEN RECEPTOR MODULATOR.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 134. ISSUE . P. 51-58 | 28 | 65% | 2 |
5 | KNOOP, A , KRUG, O , VINCENTI, M , SCHANZER, W , THEVIS, M , (2015) IN VITRO METABOLISM STUDIES ON THE SELECTIVE ANDROGEN RECEPTOR MODULATOR LG121071 AND ITS IMPLEMENTATION INTO HUMAN DOPING CONTROLS USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY.EUROPEAN JOURNAL OF MASS SPECTROMETRY. VOL. 21. ISSUE 1. P. 27 -36 | 19 | 86% | 1 |
6 | GERACE, E , SALOMONE, A , FASANO, F , COSTA, R , BOSCHI, D , DI STILO, A , VINCENTI, M , (2011) VALIDATION OF A GC/MS METHOD FOR THE DETECTION OF TWO QUINOLINONE-DERIVED SELECTIVE ANDROGEN RECEPTOR MODULATORS IN DOPING CONTROL ANALYSIS.ANALYTICAL AND BIOANALYTICAL CHEMISTRY. VOL. 400. ISSUE 1. P. 137 -144 | 25 | 68% | 8 |
7 | THEVIS, M , THOMAS, A , MOLLER, I , GEYER, H , DALTON, JT , SCHANZER, W , (2011) MASS SPECTROMETRIC CHARACTERIZATION OF URINARY METABOLITES OF THE SELECTIVE ANDROGEN RECEPTOR MODULATOR S-22 TO IDENTIFY POTENTIAL TARGETS FOR ROUTINE DOPING CONTROLS.RAPID COMMUNICATIONS IN MASS SPECTROMETRY. VOL. 25. ISSUE 15. P. 2187 -2195 | 18 | 90% | 8 |
8 | THEVIS, M , GERACE, E , THOMAS, A , BEUCK, S , GEYER, H , SCHLORER, N , KEARBEY, JD , DALTON, JT , SCHANZER, W , (2010) CHARACTERIZATION OF IN VITRO GENERATED METABOLITES OF THE SELECTIVE ANDROGEN RECEPTOR MODULATORS S-22 AND S-23 AND IN VIVO COMPARISON TO POST-ADMINISTRATION CANINE URINE SPECIMENS.DRUG TESTING AND ANALYSIS. VOL. 2. ISSUE 11-12. P. 589-598 | 23 | 70% | 8 |
9 | CAWLEY, AT , SMART, C , GREER, C , LAU, ML , KELEDJIAN, J , (2016) DETECTION OF THE SELECTIVE ANDROGEN RECEPTOR MODULATOR ANDARINE (S-4) IN A ROUTINE EQUINE BLOOD DOPING CONTROL SAMPLE.DRUG TESTING AND ANALYSIS. VOL. 8. ISSUE 2. P. 257 -261 | 13 | 100% | 1 |
10 | ZHANG, XQ , SUI, ZH , (2013) DECIPHERING THE SELECTIVE ANDROGEN RECEPTOR MODULATORS PARADIGM.EXPERT OPINION ON DRUG DISCOVERY. VOL. 8. ISSUE 2. P. 191 -218 | 38 | 35% | 16 |
Classes with closest relation at Level 1 |